As life sciences and pharmaceutical companies continue to look for new ways to unlock additional value for stockholders, they are increasingly turning to spin-off and carve-out transactions. Please join members of WilmerHale’s Capital Markets, Mergers and Acquisitions, Licensing, and Tax groups for a lively and informative panel discussion of recent developments and trends in the area of spin-off and carve-out transactions. Our panelists will discuss different ways to create value through a spin-off or carve-out transaction, keys for successfully structuring and executing the deal, and important tax considerations.
*CLE credit is not available for those who watch webinar recordings.
